A recent overview of molecular tracers for FIGS in clinical studies indicates relatively few targets being under investigation for breast cancer, i.e., folate receptor, VEGF, chlorotoxin binding proteins, HSP-90, integrins, cathepsins, and MMPs [24]. Here, CTSS is linked to breast carcinoma.